Daniel Stauder
Stock Analyst at Citizens JMP
(4.23)
# 1,482
Out of 4,683 analysts
44
Total ratings
56.4%
Success rate
22.9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniel Stauder
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STXS Stereotaxis | Maintained: Buy | $4 → $3 | $1.45 | +106.90% | 2 | Aug 27, 2026 | |
| AORT Artivion | Maintained: Buy | $53 → $48 | $27.20 | +76.47% | 10 | May 8, 2026 | |
| LMAT LeMaitre Vascular | Maintained: Buy | $118 → $127 | $79.61 | +59.53% | 11 | May 6, 2026 | |
| ATRC AtriCure | Maintained: Buy | $60 → $52 | $48.17 | +7.95% | 15 | Feb 18, 2026 | |
| STIM Neuronetics | Reiterated: Buy | $3 → $7 | $3.00 | n/a | 6 | Mar 5, 2025 |
Stereotaxis
Aug 27, 2026
Maintained: Buy
Price Target: $4 → $3
Current: $1.45
Upside: +106.90%
Artivion
May 8, 2026
Maintained: Buy
Price Target: $53 → $48
Current: $27.20
Upside: +76.47%
LeMaitre Vascular
May 6, 2026
Maintained: Buy
Price Target: $118 → $127
Current: $79.61
Upside: +59.53%
AtriCure
Feb 18, 2026
Maintained: Buy
Price Target: $60 → $52
Current: $48.17
Upside: +7.95%
Neuronetics
Mar 5, 2025
Reiterated: Buy
Price Target: $3 → $7
Current: $3.00
Upside: n/a